Meridian Bioscience Inc
VIVO
VIVO was delisted on the 30th of January, 2023.
192 hedge funds and large institutions have $733M invested in Meridian Bioscience Inc in 2020 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 69 increasing their positions, 59 reducing their positions, and 26 closing their positions.
57% more call options, than puts
Call options by funds: $2.71M | Put options by funds: $1.73M
17% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 59
12% more capital invested
Capital invested by funds: $657M → $733M (+$76.7M)
8% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 26
1% more funds holding
Funds holding: 191 → 192 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$12.2M |
| 2 |
Millennium Management
New York
|
+$7.82M |
| 3 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$7.23M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$6.97M |
| 5 |
RA
Royce & Associates
New York
|
+$6.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$9.47M |
| 2 |
Renaissance Technologies
New York
|
-$8.03M |
| 3 |
FP
Foundry Partners
Minneapolis,
Minnesota
|
-$4.9M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$4.29M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
-$3.68M |
VIVO Hedge Fund Activity: Q4 2020 in Review
192 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Meridian Bioscience Inc (VIVO) for Q4 2020, worth a combined $733M — up 12% from $657M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new VIVO positions and 26 closed out — a net gain of 2 holders — while 69 added to existing stakes and 59 trimmed.
The largest buyer was Deerfield Management, adding an estimated $12.2M. The largest seller was Kennedy Capital Management, exiting entirely with an estimated $9.47M sold.
- 192 institutional investors held Meridian Bioscience Inc (VIVO) as of Q4 2020, up from 191 in Q3 2020.
- Funds reported $733M of Meridian Bioscience Inc stock for Q4 2020, up 12% quarter-over-quarter.
- 28 funds opened new Meridian Bioscience Inc positions in Q4 2020 and 26 closed out, a net change of +2 holders.
- The largest Meridian Bioscience Inc buyer in Q4 2020 was Deerfield Management, an estimated $12.2M added.
- The largest Meridian Bioscience Inc seller in Q4 2020 was Kennedy Capital Management, an estimated $9.47M sold.
Based on aggregated 13F filings for Q4 2020.